Effect of adenovirus-mediated transfer of the CTLA4IG gene in hamster-to-rat xenotransplantation

Transplantation

Volumn 80, Issue 4, 2005, Pages 494-499

  Hayashi, Shuji ^a   Leu, Daikaku ^a   Yamii, Yasushi ^a   Mei, Guanlin ^a   Takagi, Hiroshi ^b   Nakao, Akimasa ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JR Tokai Hospital   (Japan)

Author keywords

Costimulatory signal; Gene therapy; Xenotransplantation

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; COMPLEMENTARY DNA; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE TRANSFER; GRAFT SURVIVAL; HAMSTER; HEART TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSGENE; XENOTRANSPLANTATION;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, VIRAL; CRICETINAE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOCONJUGATES; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; MALE; RATS; RATS, WISTAR; TACROLIMUS; TRANSPLANTATION, HETEROLOGOUS;

EID: 23944460477     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000168151.83816.f4     Document Type: Article

References (33)

1. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990; 248: 1349.
2. Wu Y, Guo Y, Liu Y. A major costimulatory molecule on antigen-presenting cell. J Exp Med 1993; 178: 1789.
3. Tao P, Anasetti C, Hansen JA, et al. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking intereaction of CD28 with its natural ligand B7/BB1. J Exp Med 1993; 177(1): 165.
4. Hale DA, Gottschalk R, Maki T, Monaco AP. Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival. Transplantation 1997; 64(6): 897.
5. Kroshus TJ, Bolman III RM, Dalmasso AP, et al. Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model. Transplantation 1996; 61(10): 1513.
6. Rosengard AM, Gary NRB, Langford GA, et al. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. Transplantation 1995; 59(9): 1325.
7. Sandrin MS, Vaughan HA, McKenzie FC. Identification of Gal(α1,3)Gal as the major epitope for pig-to-human vascularised xenografts. Transplant Rev 1994; 8(3): 134.
8. Verma IM, Somia N. Gene therapy-promises, problems and prospects. Nature 1997; 389: 239.
9. Ishibashi S, Brown MS, Goldstein JL, et al. Hypercholesteromia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993; 92: 883.
10. Dai Y, Schwarz EM, Gu D, et al. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci USA 1995; 92(5): 1401.
11. Yang Y, Ertl HCJ, Wilson JM. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with ED1-deleted recombinant adenovirus. Immunity 1994; 1: 433.
12. Olthoff KM, Judge TA, Gelman AE, et al. Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4Ig. Nature Med 1998; 4(2): 194.
13. Kita Y, Li XK, Fyneshima N, et al. Prolonged cardiac allograft survival in rats systemically injected adenoviral vectors containing CTLA4Ig-gene. Transplantation 1999; 68(6): 758.
14. Ono K, Lindsey ES. Improved techniques of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 7: 225.
15. Miyake S, Makimura M, Kanegae Y, et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length genome. Proc Natl Acad Sci USA 1996; 93(3): 1320.
16. Linsley PS, Wallace PM, Johnson J, et al. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 1992; 257: 792.
17. Lafferty KJ, Prowse SJ, Smeonovic CJ. Immunobiology of tissue transplantation: A return to passenger leukocyte concept. Annu Rev Immunol 1983; 1: 143.
18. Quill H, Schwartz RH. Stimulation of normal inducer T cell clonals with antigen presented by purified Ia molecules in planar lipid membranes: Specific induction of a long-lived state of proliferative nonresponsiveness. J Immunol 1987; 138: 3704.
19. Jenkins MK, Schwartz RH. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 1987; 165: 302.
20. Jenkins MK, Burrell E, Ashwell JD. Antigen presentation by resting B cells: Effectiveness at inducing T cell proliferation is determined by costimulatory signals, not T cell receptor occupancy. J Immunol 1990; 144: 1585.
21. Springer T. Adhesion receptor of the immune system. Nature 1990; 346: 425.
22. Boussitis VA, Freeman GJ, Gray G, et al. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantiogen-specific tolerance. J Exp Med 1993; 178: 1753.
23. June CH, Ledbetter JA, Linsley PS, Thompson CB. Role of the CD28 receptor in T-cell activation. Immunol Today 1990; 11: 191.
24. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993; 11: 191.
25. Freeman GJ, Gribben JG, Boussiotis VA, et al. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993; 262: 909.
26. Pearson TC, Alexander DZ, Hendrix R, et al. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor-specific unresponsiveness in the model. Transplantation 1996; 61: 997.
27. Kirk DK, Harlan DM, Armstrong NN, et al. CTLA-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 1997; 94: 8789.
28. Hayashi S, Mei GL, Yokoyama I, et al. Adenovirus-mediated gene transfer of CTLA4Ig gene results in prolonged surival of heart allograft. Transplanat Int 2001; 3: 329.
29. Sho M, Sandner SE, Najarian N, et al. New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs. Ann Surg 2002; 236: 667.
30. Lenschow DJ, Zeng Y, Thistlethwaite JR, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992; 257: 789.
31. Nakeyama K, Yasunami Y, Toyofuku A, et al. Beneficial effects of costimulatory blockade with anti-inducible costimulator antibody in conjunction with CTLA4Ig on prevention of islet xenograft rejection from rat to mouse. Transplantation 2004; 78: 1590.
32. Wang N, Lee JM, Tobiasch E, et al. Induction of xenograft accommodated by modulation of elicited antibody responses. Transplantation 2002; 74: 334.
33. Raper SE, Chirmule N, Lee FS, et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 2003; 80: 148.